Uterine sarcoma in Israel: a study of 104 cases.
Data gathered during the first epidemiologic study of sarcoma of the uterus in Israel are presented. In the 7-year period of this survey, 104 new cases of sarcoma of the uterus were diagnosed, representing an incidence of 1.55/100,000 females over the age of 20. Half of the patients were in their fifth and sixth decades of life at the diagnosis of the tumor. Uterine sarcomas were more prevalent in women of European-American origin than in those of Asian-African descent. In 54.9% of the patients the diagnosis was made while the disease was in stage I. A definite correlation between sarcoma of the uterus, diabetes, hypertension, and obesity was not found. The 5-year survival rate in the present survey was 38%. Factors affecting prognosis were the clinical stage of the disease at diagnosis, histologic type, and the method of treatment.
Schwartz
Z
Z
Dgani
R
R
Lancet
M
M
Kessler
I
I
D000328:Adult; D000367:Age Factors; D000368:Aged; D005006:Ethnicity; D005260:Female; D006801:Humans; D007557:Israel; D007585:Jews; D007890:Leiomyosarcoma / Q000453:epidemiology; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009373:Neoplasms, Germ Cell and Embryonal / Q000453:epidemiology; D010298:Parity; D011379:Prognosis; D012208:Rhabdomyosarcoma / Q000453:epidemiology; D012509:Sarcoma / Q000453:epidemiology* / Q000401:mortality / Q000628:therapy; D014594:Uterine Neoplasms / Q000453:epidemiology* / Q000401:mortality / Q000628:therapy